Press Releases http://www.insightec.com/18037.html en 01/08/2010 11:32:22 10 32 233 http://www.insightec.com/18037.html http://www.insightec.com/contentManagment/uploadedFiles/template/logo.gif FDA Approves Use of InSightec’s ExAblate 2000 with GE Healthcare’s 3 Tesla Magnetic Resonance Imaging System http://www.insightec.com/18378.html Non-invasive Magnetic Resonance-guided Focused Ultrasound Uterine Fibroid Treatment Now Compatible With Both 1.5 Tesla and 3 Tesla Systems FDA Approves New Version of InSightec’s ExAblate 2000 That Speeds Up Treatment Time http://www.insightec.com/18377.html More Women Now Eligible For the Only Incisionless Treatment Option For Symptomatic uterine fibroids InSightec’s ExAblate 2000 Magnetic Resonance guided Focused Ultrasound (MRgFUS) System is Approved for Sale in Canada http://www.insightec.com/18376.html MRgFUS Offers Women the Only Non-Invasive Treatment for Symptomatic Uterine Fibroids InSightec Receives the Red Herring 100 Europe 2007 Award http://www.insightec.com/18375.html Award Recognizes the 100 “Most Promising” Companies Driving the Future of Technology InSightec Encourages Uterine Fibroid Sufferers to ask their Doctors about Less Invasive Treatment Options http://www.insightec.com/18374.html MR guided Focused Ultrasound offers non-invasive alternative to hysterectomy and myomectomy InSightec Receives European CE Mark for ExAblate 2000 Treatment of Pain Caused By Bone Metastases http://www.insightec.com/18373.html InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors http://www.insightec.com/18372.html InSightec Announces Change to European CE Mark for ExAblate® 2000 in Uterine Fibroids http://www.insightec.com/18371.html Patients with symptomatic uterine fibroids who wish to preserve fertility now have the option to undergo this non-invasive procedure InSightec Ltd. announces $30 Million Investment Round http://www.insightec.com/18370.html InSightec Selected as a 2008 World Economic Forum Technology Pioneer http://www.insightec.com/18369.html